By Don Scansen  11.10.2020

The 5G era is well underway, though the rollout is still relatively new, and with only a few handsets capable of all the available spectrum, there are still questions that consume column space.

The upper portion of the spectrum offers opportunities to investigate since the mmWave band at 28 GHz currently available is new to the consumer market. Higher frequencies are coming later. Extra high frequency, or EHF, is the moniker for 30 to 300 GHz which may provide a clue as to why there are people who want to understand potential health impacts before they embrace this new technology.

Although the upper reaches of the 5G spectrum offer both higher potential bandwidths and open frequency allocations now given to cellular service, this range of frequencies suffers from very high atmospheric attenuation. That raises the potential for higher power outputs required at antennas in order to reliably connect a user to a base station cell.

But the open air attenuation is just part of the issue. The use of mmWave frequencies is new, but another issue is not. The flesh and blood and bone of the user will also absorb the RF energy. I will not address the potential biological reaction to the mmWave energy. Whether or not the user will experience physical effects, the hand or head (or any body part) will definitely reduce if not outright eliminate RF signal propagation for 5G (at least you hope the output power is in the range that makes this true).

Read more at: https://www.eetimes.com/5g-antennas-stay-out-of-the-way/

The post 5G Antennas – Stay Out of the Way appeared first on EMFSA.

The post Effect of cell-phone radiofrequency on angiogenesis and cell invasion in human head and neck cancer cells. appeared first on EMFSA.

The post International policy and advisory response regarding children’s exposure to radio frequency electromagnetic fields (RF-EMF). appeared first on EMFSA.

Cancers in the head and neck are increasing in Sweden

The Swedish Radiation Safety Authority and some experts with ties to industry have argued during the last years that there are no health risks from mobile phone use since there is no increased incidence in brain tumours in Swedish and other cancer registries. This new data shows that the argument is not only wrong from an ethical point, it is also not in line with the data.

The Swedish Radiation Protection Foundation urges that the public is broadly informed about the health risks and that urgent measures to protect children and adults from health risks from mobile phone radiation are put in place, in line with the demand from over 230 scientists in EMF Scientists appeal, signed by 236 scientists. https://www.emfscientist.org/index.php/emf-scientist-appeal

Recently, Lennart Hardell’s group published a new article on brain tumor rates in Sweden using the Inpatient Register for the time period 1998-2015. Also incidence data using the Swedish Cancer Register was analyzed for the same time period. The full article can be found here http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0185461 The abstract is below.

Hardell’s group used the Swedish Inpatient Register (IPR) to analyze rates of brain tumors of unknown type (D43) during 1998-2015. Average Annual Percentage Change (AAPC) per 100,000 increased with +2.06%, 95% confidence interval (CI) +1.27, +2.86% in both genders combined. A joinpoint was found in 2007 with Annual Percentage Change (APC) 1998-2007 of +0.16%, 95% CI -0.94, +1.28%, and 2007-2015 of +4.24%, 95% CI +2.87, +5.63%. Highest AAPC was found in the age group 20-39 years. In the Swedish Cancer Register the age-standardized incidence rate per 100,000 increased for brain tumors, ICD-code 193.0, during 1998-2015 with AAPC in men +0.49%, 95% CI +0.05, +0.94%, and in women +0.33%, 95% CI -0.29, +0.45%. The cases with brain tumor of unknown type lack morphological examination. Brain tumor diagnosis was based on cytology/histopathology in 83% for men and in 87% for women in 1980 in the Cancer Register. This frequency increased to 90% in men and 88% in women in 2015. During the same time period CT and MRI imaging techniques were introduced and morphology is not always necessary for diagnosis. If all brain tumors based on clinical diagnosis with CT or MRI had been reported to the Cancer Register the frequency of diagnoses based on cytology/histology would have decreased in the register. The results indicate underreporting of brain tumor cases to the Cancer Register. The real incidence would be higher. Thus, incidence trends based on the Cancer Register should be used with caution. Use of wireless phones should be considered in relation to the change of incidence rates.

Further reading:

BioInitiative Report: Medical concerns intensify over deadly brain tumors from cell phone use / Orebro University Hospital, Orebro, Sweden/November 17, 2017

Press Announcement BioInitiative Working Group 2017

BioInitiative Report: Medical concerns intensify over deadly brain tumors from cell phone use / Orebro University Hospital, Orebro, Sweden/November 17, 2017

This new update from the BioInitiative Working Group 2017 shows the evidence has strengthened for brain cancers related to wireless phone use. The Group has released an update analyzing scientific results of case-control studies published between 2010 and 2017 on cancers of the brain.

For glioma, a malignant brain cancer with a very poor survival rate especially for high-grade
glioma, there is nearly a doubling of the risk overall if the cell phone is used for 1,640 hours or
more. If the cell phone is used primarily on the same side of the head however, the odds of
getting a tumor on that side of the head increase to more than two and a half times compared to
those with no wireless phone exposure.
Survival time after brain tumor diagnosis is also shorter with wireless phone use in patients with
glioblastoma multiforme, compared to patients with no use.

“There is a consistent pattern of increased risk for glioma (a malignant brain tumor) and
acoustic neuroma with use of mobile and cordless phones” says Lennart Hardell, MD, PhD,
Orebro University, Sweden, according to publications through mid-2017. “Epidemiological
evidence shows that radiofrequency should be classified as a Group 1 (Known) Human
Carcinogen. The evidence for risks to health from brain tumors has substantially increased since
2010. The existing FCC/IEEE and ICNIRP public safety limits are not adequate to protect public
health.”
An increased risk in acoustic neuroma (a non-malignant tumor of the auditory nerve) is also
reported. Cell phone users with 1,640 hours or more of use are nearly two and three-quarters
more likely than non-users to develop an acoustic neuroma when the phone is used primarily on
the side of the head where the tumor occurs.
Both cell phones and cordless phones pose a risk of brain tumors.

Link to the Bioinitiative Press Announcement below:http://www.bioinitiative.org/bioinitiative-report-medical-concerns-intensify-over-deadly-brain-tumors-from-cell-phone-use-orebro-university-hospital-sweden-november-17-2017/

BioInitiative Report Supplement 11, 2017, Hardell and Carlberg Hardell-2017-Sec11-Update-Use_of_Wireless_Phones

The post Cancer incidence data from the Swedish Cancer Registry January 2018 appeared first on EMFSA.